Upgrades/Downgrades
Updated: 11-Jun-26 16:30 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Tidewater | TDW | Pickering Energy Partners | Underperform » Neutral | ||
| Allegion | ALLE | Longbow | Neutral » Buy | $165 | |
| Tronox | TROX | Truist | Sell » Hold | $7 | |
| Intel | INTC | BofA Securities | Underperform » Buy | $135 | |
| Henry Schein | HSIC | BTIG Research | Neutral » Buy | $100 | |
| General Dynamics | GD | Jefferies | Hold » Buy | $400 | |
| CME Group | CME | Rothschild & Co Redburn | Neutral » Buy | $323 | |
| Black Hills Corp | BKH | BofA Securities | Neutral » Buy | $78 | |
| BASF AG | BASFY | Kepler | Hold » Buy | ||
| Arthur J. Gallagher | AJG | Jefferies | Hold » Buy | $265 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Healthpeak Properties | DOC | Morgan Stanley | Overweight » Equal-Weight | $22 | |
| Alexandria RE | ARE | Morgan Stanley | Equal-Weight » Underweight | $53 | |
| Vodafone PLC | VOD | Barclays | Overweight » Equal Weight | ||
| PROCEPT BioRobotics | PRCT | Leerink Partners | Outperform » Market Perform | $29 | |
| MarketAxess | MKTX | Rothschild & Co Redburn | Buy » Neutral | $134 | |
| J. Jill | JILL | William Blair | Outperform » Mkt Perform | ||
| Chewy | CHWY | MoffettNathanson | Buy » Neutral | ||
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Kazia Therapeutics | KZIA | Lake Street | Buy | $32 | |
| CitroTech | CITR | Northland Capital | Outperform | $16 | |
| Westwater Resources | WWR | D. Boral Capital | Buy | $3 | |
| Waters | WAT | Piper Sandler | Neutral | $400 | |
| Voyager Technologies | VOYG | BTIG Research | Buy | $55 | |
| Thermo Fisher | TMO | Piper Sandler | Neutral | $510 | |
| Super Micro Computer | SMCI | Wolfe Research | Peer Perform | ||
| SpaceX | SPCX | Oppenheimer | Outperform | ||
| Septerna | SEPN | Guggenheim | Buy | $52 | |
| Sensei Biotherapeutics | SNSE | BTIG Research | Buy | $55 | |
| Nervgen Pharma | NGEN | TD Cowen | Buy | ||
| Energy Vault | NRGV | Citigroup | Neutral | $5.25 | |
| Danaher | DHR | Piper Sandler | Neutral | $200 | |
| Damora Therapeutics | DMRA | H.C. Wainwright | Buy | $45 | |
| Daktronics | DAKT | Roth Capital | Buy | $26 | |
| Bio-Techne | TECH | Piper Sandler | Neutral | $65 | |
| Agilent | A | Piper Sandler | Neutral | $150 | |
| Advanced Energy | AEIS | Cantor Fitzgerald | Overweight | $400 | |
| Advanced Drainage Systems | WMS | Jefferies | Buy | $175 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Sutro Biopharma | STRO | Truist | Buy | $50 | |
| Toast | TOST | Piper Sandler | Overweight | $32 | |
| CRISPR Therapeutics | CRSP | Morgan Stanley | Equal-Weight | $60 | |
| Community Trust Bancorp | CTBI | Piper Sandler | Neutral | $76 | |
| Callaway Golf Company | CALY | Goldman | Neutral | $17 | |
|
|
|||||
| Coverage Reiterated/Price Tgt Changed* | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Six Flags Entertainment | FUN | UBS | Buy | $27 » $30 | |
| Micron | MU | Wolfe Research | Outperform | $550 » $1250 | |
| Generac | GNRC | UBS | Buy | $305 » $335 | |
| Ford Motor | F | Goldman | Neutral | $13 » $16 | |
| Navan | NAVN | BMO Capital Markets | Outperform | $22 » $30 | |
| Oracle | ORCL | BMO Capital Markets | Outperform | $200 » $220 | |
| Oxford Industries | OXM | Telsey Advisory Group | Market Perform | $51 » $44 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |